Cortexyme, Inc. (CRTX) |
| 1.95 0.05 (2.63%) 08-01 00:00 |
| Open: | 1.91 |
| High: | 1.97 |
| Low: | 1.86 |
| Volume: | 272,208 |
| Market Cap: | 70(M) |
| PE Ratio: | -0.66 |
| Exchange: | NASDAQ Global Select |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
| sell | buy | |||
| Resistance 2: | |
| Resistance 1: | |
| Pivot price: | |
| Support 1: | |
| Support 2: | |
| 52w High: | |
| 52w Low: |
Cortexyme, Inc., a clinical stage biopharmaceutical company, focuses on developing therapeutics for Alzheimer's and other degenerative diseases. Its lead drug candidate is atuzaginstat (COR388), an orally administered brain-penetrating small molecule gingipain inhibitor, which is in Phase II/III clinical trial for use in patients with mild to moderate Alzheimer's disease, as well as for the treatment of oral squamous cell carcinoma, periodontitis, and coronavirus infection. The company was incorporated in 2012 and is headquartered in South San Francisco, California.
Financials
| EPS | |
| Book Value | |
| PEG Ratio | |
| Gross Profit |
| Profit Margin (%) | |
| Operating Margin (%) | |
| Return on Assets (ttm) | |
| Return on Equity (ttm) |
Company news
Mon, 14 Feb 2022
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Cortexyme, Inc. with Losses of $100,000 to Contact the Firm - CEO Today
Tue, 01 Feb 2022
After Alzheimer's drug flop, Peninsula biotech's founding execs exit - The Business Journals
Wed, 27 Oct 2021
Why an Alzheimer's-focused biotech hoping to 'change the world' shed 70% of its value - The Business Journals
Wed, 27 Oct 2021
Alzheimer’s Disease Stock Cortexyme Craters on Trial Failure - Bloomberg.com
Wed, 27 Oct 2021
Here's Why Cortexyme Is Imploding on Wednesday - The Motley Fool
Thu, 08 Jul 2021
Peter Thiel's 'audacious' early-stage science Breakout Labs fund is winding down - San Francisco Business Times - The Business Journals
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
